EXHIBIT 12. STATEMENT RE: AMENDED COMPUTATION OF RATIO OF EARNINGS FROM CONTINUING OPERATIONS TO FIXED CHARGES (Unaudited) Eli Lilly and Company and Subsidiaries (Dollars in millions) Three Months Ended Years Ended December 31, March 31, -------------------------------------------------- 1999 1998 1997 1996 1995 1994 ----------------------------------------------------------------------- Consolidated Pretax Income from Continuing Operations before Accounting Changes & Extraordinary Item....... $543.5 $2,665.0 $2,901.1 $2,131.3 $1,866.6 $1,693.3 Interest from Continuing Operations and Other Fixed Changes...................... 48.7 198.3 253.1 323.8 323.9 128.7 Less Interest Capitalized during the Period from Continuing Operations.............. (4.8) (17.0) (20.4) (35.8) (38.3) (25.4) ----------------------------------------------------------------------- Earnings............................. $587.4 $2,846.3 $3,133.8 $2,419.3 $2,152.2 $1,796.6 ======================================================================= Fixed Charges /1/.................... $ 48.8 $ 200.5 $ 256.8 $ 328.5 $ 323.9 $ 128.7 ======================================================================= Ratio of Earnings to Fixed Charges...................... 12.0 14.2 12.2 7.4 6.6 14.0 ======================================================================= /1/ Fixed charges include interest from continuing operations for all years presented and beginning in 1996, preferred stock dividends. 4